ARTICLES
-
-
Year
-
-
- Practices
-
Chinese Mainland Capital MarketsHong Kong & Overseas Capital MarketsInvestment/M&A & Corporate GovernanceCross-border Investment/M&AConstruction & Project DevelopmentFinancingDebt Restructuring & Non-performing AssetsTaxation & Wealth PlanningPrivate Equity & Investment FundsFinancial Products & TrustsLitigation & ArbitrationCorporate & Commercial CrimeBankruptcy, Insolvency & ReorganizationShippingCompliance & InvestigationAntitrust & CompetitionTrade Compliance & Trade RemediesCustoms & Import/ExportLabor & EmploymentHealth, Safety & Environmental ProtectionIP Licensing & EnforcementTrademark ProsecutionPatent ProsecutionCybersecurity & Data Protection
-
- Industries
-
Real EstateUrban InfrastructureTransportation & LogisticsTourism & HospitalityEnergy & PowerMining & Natural ResourcesBanking & Financial ServicesInsuranceFinancial Innovation & FintechTelecommunications & InternetInformation & Intelligence TechnologyHealthcarePharmaceuticals & Life SciencesEducation & TrainingMedia-Sports & EntertainmentNational Defense & Military IndustryRetail & Consumer ProductsIndustry & ManufacturingAgriculture & Food
-
- Latest
- Most relevant
-
-
2024-12-09
Key Takeaways: Picking Local Delegates in China for Drug MAHs
Key considerations for selecting and managing Local Delegates by foreign drug MAHs.
-
2024-10-28
Green Finance Framework and Financial Instruments in China
Development of China’s green finance system and major financial instruments.
-
2024-10-25
PRC Customs Voluntary Disclosure: Technical Challenges & Impacts
Customs disclosure policies benefit enterprises, yet firms need to assess policy applicability to avoid future issues.
-
2024-10-21
The Path Ahead: Foreign Investment under New Healthcare Policies
The article discusses China’s new healthcare policies, analyzing their potential trends.
-
2024-09-09
China’s CGT Foreign Investment Ban Lifted - Opportunities and Challenges
本文讨论了放宽外资在细胞与基因治疗（CGT）领域的准入限制后，跨国公司在投资CGT过程中可能面临的风险、原有VIE架构拆除的复杂性以及在开展与CGT相关的IIT和CGT产品注册时的关注点。